Literature DB >> 8360493

Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.

N Yamamoto1, R Kumashiro.   

Abstract

Highly conserved DBP (human DBP is known as Gc) of serum alpha 2-globulin fraction can be converted to a potent macrophage activating factor by stepwise modification of Gc glycoprotein with beta-galactosidase of B cells and sialidase of T cells. These glycosidases, beta-galactosidase and sialidase, are membrane bound and not soluble in culture medium. Thus, consecutive contact of Gc protein with B cells and T cells, presumably via specific receptors, is required for conversion of Gc glycoprotein to the macrophage activating factor. The essential role of T cell sialidase in macrophage activation was confirmed by the finding that peritoneal nonadherent cells of SM/J mouse, whose T cells are deficient in sialidase activity, were unable to convert Gc protein to the macrophage activating factor and thus did not activate macrophages. Treatment with sialidase of a conditioned medium of lipid metabolite-treated SM/J mouse nonadherent cells efficiently generated the macrophage activating factor. When Gc protein was first treated with soluble or immobilized sialidase and used in a medium for 2 h cultivation of lipid metabolite-treated SM/J mouse nonadherent cells or BALB/c mouse B cells, the resultant conditioned media contained a large amount of the macrophage activating factor. These results support the hypothesis that Gc protein carries a dibranched trisaccharide with galactose and sialic acid termini.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360493

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

2.  Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.

Authors:  Chad R Borges; Jason W Jarvis; Paul E Oran; Stephen P Rogers; Randall W Nelson
Journal:  J Biomol Tech       Date:  2008-07

Review 3.  The emerging role of vitamin D binding protein in multiple sclerosis.

Authors:  Giulio Disanto; Sreeram V Ramagopalan; Andrea E Para; Lahiru Handunnetthi
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

4.  Modification of alpha 2-macroglobulin into a macrophage-activating factor through the action of liposome-stimulated B-cell membranous glycosidases.

Authors:  M Murai; Y Aramaki; S Tsuchiya
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

5.  Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.

Authors:  Mingyang Song; Gauree Gupta Konijeti; Chen Yuan; Ashwin N Ananthakrishnan; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Kimmie Ng; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-31

6.  A carbohydrate neoepitope that is up-regulated on human mononuclear leucocytes by neuraminidase treatment or by cellular activation.

Authors:  M T Quinn; S D Swain; C A Parkos; K L Jutila; D W Siemsen; S L Kurk; A J Jesaitis; M A Jutila
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

Review 7.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

8.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

9.  Regulation of phagocytosis in macrophages by neuraminidase 1.

Authors:  Volkan Seyrantepe; Alexandre Iannello; Feng Liang; Evgeny Kanshin; Preethi Jayanth; Suzanne Samarani; Myron R Szewczuk; Ali Ahmad; Alexey V Pshezhetsky
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

10.  Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells.

Authors:  S Zhang; J D McCarter; Y Okamura-Oho; F Yaghi; A Hinek; S G Withers; J W Callahan
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.